First Time Loading...

Meridian Bioscience Inc
NASDAQ:VIVO

Watchlist Manager
Meridian Bioscience Inc Logo
Meridian Bioscience Inc
NASDAQ:VIVO
Watchlist
Price: 33.97 USD
Updated: Mar 28, 2024

Wall Street
Price Targets

VIVO Price Targets Summary
Meridian Bioscience Inc

There are no price targets for VIVO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Meridian Bioscience Inc Competitors:
Price Targets
SDI
SDI Ltd
76% Downside
HAE
Haemonetics Corp
27% Upside
7447
Nagaileben Co Ltd
14% Downside
SUPERMX
Supermax Corporation Bhd
21% Upside
688029
Micro-Tech Nanjing Co Ltd
59% Upside
6491
Pegavision Corp
4% Downside
300595
Autek China Inc
78% Upside
NEOG
Neogen Corp
25% Upside

Revenue
Forecast

Revenue Estimate
Meridian Bioscience Inc

For the last 8 years the compound annual growth rate for Meridian Bioscience Inc's revenue is 7%. The projected CAGR for the next 1 year is -12%.

7%
Past Growth
-12%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Meridian Bioscience Inc

For the last 8 years the compound annual growth rate for Meridian Bioscience Inc's operating income is 5%. The projected CAGR for the next 1 year is -38%.

5%
Past Growth
-38%
Estimated Growth
Estimates Accuracy
6%
Average Beat

Net Income
Forecast

Net Income Estimate
Meridian Bioscience Inc

For the last 8 years the compound annual growth rate for Meridian Bioscience Inc's net income is 3%. The projected CAGR for the next 1 year is -13%.

3%
Past Growth
-13%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VIVO's stock price target?
Not Available

VIVO doesn't have any price targets made by Wall Street professionals.

What is Meridian Bioscience Inc's Revenue forecast?
Projected CAGR
-12%

For the last 8 years the compound annual growth rate for Meridian Bioscience Inc's revenue is 7%. The projected CAGR for the next 1 year is -12%.

What is Meridian Bioscience Inc's Operating Income forecast?
Projected CAGR
-38%

For the last 8 years the compound annual growth rate for Meridian Bioscience Inc's operating income is 5%. The projected CAGR for the next 1 year is -38%.

What is Meridian Bioscience Inc's Net Income forecast?
Projected CAGR
-13%

For the last 8 years the compound annual growth rate for Meridian Bioscience Inc's net income is 3%. The projected CAGR for the next 1 year is -13%.